FI944014A0 - Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina - Google Patents

Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina

Info

Publication number
FI944014A0
FI944014A0 FI944014A FI944014A FI944014A0 FI 944014 A0 FI944014 A0 FI 944014A0 FI 944014 A FI944014 A FI 944014A FI 944014 A FI944014 A FI 944014A FI 944014 A0 FI944014 A0 FI 944014A0
Authority
FI
Finland
Prior art keywords
macrolides
pct
immunosuppressants
antifungal agents
desosamine
Prior art date
Application number
FI944014A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI944014A (fi
Inventor
James R Hauske
Gary R Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI944014A publication Critical patent/FI944014A/fi
Publication of FI944014A0 publication Critical patent/FI944014A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI944014A 1992-03-02 1994-09-01 Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina FI944014A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435092A 1992-03-02 1992-03-02
PCT/US1993/000426 WO1993018042A1 (fr) 1992-03-02 1993-01-27 Derives de desosamino de macrolides utiles comme immunosuppresseurs et antifongiques

Publications (2)

Publication Number Publication Date
FI944014A FI944014A (fi) 1994-09-01
FI944014A0 true FI944014A0 (fi) 1994-09-01

Family

ID=25292478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944014A FI944014A0 (fi) 1992-03-02 1994-09-01 Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina

Country Status (12)

Country Link
US (2) US5506233A (fr)
EP (1) EP0629203B1 (fr)
JP (1) JPH07500613A (fr)
AT (1) ATE205496T1 (fr)
CA (1) CA2131371A1 (fr)
DE (1) DE69330747T2 (fr)
DK (1) DK0629203T3 (fr)
ES (1) ES2160593T3 (fr)
FI (1) FI944014A0 (fr)
GR (1) GR3037059T3 (fr)
PT (1) PT629203E (fr)
WO (1) WO1993018042A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2182004C1 (ru) * 2001-02-22 2002-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственный препарат для парентерального применения
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP1474404A4 (fr) * 2002-02-13 2006-01-11 Biogal Gyogyszergyar Procede d'extraction d'un macrolide a partir d'une matiere biologique
US7452692B2 (en) * 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
TW200504079A (en) * 2003-03-31 2005-02-01 Biogal Gyogyszergyar Crystallization and purification of macrolides
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
CA2533548C (fr) * 2003-07-24 2010-02-16 Teva Gyogyszergyar Reszvenytarsasag Procede de purification de macrolides
CA2571710A1 (fr) 2004-06-24 2006-11-02 Nicholas Valiante Immuno-potentialisateurs a petites molecules et analyses visant a detecter leur presence
WO2006069333A1 (fr) * 2004-12-22 2006-06-29 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Procede de purification de macrolides
WO2006083486A1 (fr) * 2005-01-05 2006-08-10 TEVA GYÓGYSZERGYÁR ZÁRTKöR..EN M..k..D.. RÉSZVÉNYTÁRSASÁG Tacrolimus amorphe et sa preparation
EP2671508B1 (fr) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Système pharma-informatique
JP4700022B2 (ja) * 2006-03-15 2011-06-15 アイバックス ファーマシューティカルズ スポレツノスト エス ルチェニム オメゼニム タクロリマスの精製方法
JP2009203162A (ja) * 2006-06-05 2009-09-10 Astellas Pharma Inc マクロライド化合物の新規製造法
CA2663377A1 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap)
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JPH05504944A (ja) * 1989-08-18 1993-07-29 藤沢薬品工業株式会社 巨大環式化合物
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
JPH07500613A (ja) 1995-01-19
ES2160593T3 (es) 2001-11-16
DE69330747T2 (de) 2002-05-29
DK0629203T3 (da) 2001-11-12
FI944014A (fi) 1994-09-01
US5506233A (en) 1996-04-09
CA2131371A1 (fr) 1993-09-16
EP0629203A1 (fr) 1994-12-21
PT629203E (pt) 2002-01-30
WO1993018042A1 (fr) 1993-09-16
DE69330747D1 (de) 2001-10-18
GR3037059T3 (en) 2002-01-31
EP0629203B1 (fr) 2001-09-12
US5563135A (en) 1996-10-08
ATE205496T1 (de) 2001-09-15

Similar Documents

Publication Publication Date Title
FI944014A (fi) Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
FR2686084B1 (fr) Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
ES2118250T3 (es) Combinaciones germicidas de substancias activas.
DE69423781D1 (de) Rapamycin-derivate als immunosuppressoren
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
DE68918944D1 (de) Künstliche rezeptor-analoge.
MX9401406A (es) Agentes receptores de adenosina selectivos para intensificar el conocimiento.
FR2775288B1 (fr) Derives de streptogramines, leur preparation et les compositons qui les contiennent
PT1044203E (pt) Derivados epimericos 3' do k-252a
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
IT234656Y1 (it) Gruppo costruttivo per cassetti.
ATE159725T1 (de) 2-aminozuckermakrolid-derivate
DK0629209T3 (da) Sukkerderivater af makrolider
ES2089669T3 (es) Utilizacion de los derivados de isoquinolinona en el tratamiento de la hiperlipoproteinemia.
Zong Closing Speech of the Second Meeting of the CNCNST
BG95867A (bg) Метод за обработване на кожи,причиняващи слабо замъгляване
DE69407180D1 (de) Fluoro-nukleosid-reinigung
GR1001394B (el) Παράγωγα 4-[4-[4-(4-υδροξυφαινυλ)-1-πιπεραζινυλ] φαινυλ]-5-με?υλ3Η-1,2,4-τριαζολ-3-όνης.
ITMO920109A0 (it) Gioco di apprendimento del linguaggio musicale, impiegante piccole parti mobili
FI920347A0 (fi) Foerfarande foer reglering av blandningsfoerhaollandet och stroemningsmaengderna av gas vid framstaellning av roekgaser i synnerhet foer roekning av livsmedel.
FI922399A (fi) Haollare foer upphaengning av boecker el.dyl.
FI905233A0 (fi) Foerfarande foer identifiering av fraemmande aemnen i gas vid jonisationsmaetningar.